These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23619024)

  • 1. Cryotherapy protocols for metastatic breast cancer after failure of radical surgery.
    Niu L; Mu F; Zhang C; Li Y; Liu W; Jiang F; Li L; Liu C; Zeng J; Yao F; Chen J; Li J; Zuo J; Xu K
    Cryobiology; 2013 Aug; 67(1):17-22. PubMed ID: 23619024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic outcomes of combining cryotherapy, chemotherapy and DC-CIK immunotherapy in the treatment of metastatic non-small cell lung cancer.
    Yuanying Y; Lizhi N; Feng M; Xiaohua W; Jianying Z; Fei Y; Feng J; Lihua H; Jibing C; Jialiang L; Kecheng X
    Cryobiology; 2013 Oct; 67(2):235-40. PubMed ID: 23948179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination treatment with comprehensive cryoablation and immunotherapy in metastatic pancreatic cancer.
    Niu L; Chen J; He L; Liao M; Yuan Y; Zeng J; Li J; Zuo J; Xu K
    Pancreas; 2013 Oct; 42(7):1143-9. PubMed ID: 23899940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment outcomes and clinicopathologic characteristics of advanced triple-negative breast cancer patients].
    Zhang P; Xu BH; Ma F; Li Q; Yuan P; Wang JY; Zhang P
    Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):381-4. PubMed ID: 21875471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous comprehensive cryoablation for metastatic esophageal cancer after failure of radical surgery.
    Jiongyuan X; Lizhi N; Feng M; Shupeng L; Yin L; Mengtian L; Jianying Z; Fei Y; Jibing C; Jialiang L; Kecheng X
    Cryobiology; 2013 Dec; 67(3):363-8. PubMed ID: 24383130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of a phase II study of pemetrexed as first-line chemotherapy in patients with advanced or metastatic breast cancer.
    Robert NJ; Conkling PR; O'Rourke MA; Kuefler PR; McIntyre KJ; Zhan F; Asmar L; Wang Y; Shonukan OO; O'Shaughnessy JA
    Breast Cancer Res Treat; 2011 Feb; 126(1):101-8. PubMed ID: 21188632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-naïve patients with locally advanced or metastatic breast carcinoma.
    Hsu C; Huang CS; Chao TY; Lu YS; Bu CF; Chen MM; Chang KJ; Cheng AL
    Cancer; 2002 Nov; 95(10):2044-50. PubMed ID: 12412156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination treatment with comprehensive cryoablation and immunotherapy in metastatic hepatocellular cancer.
    Niu LZ; Li JL; Zeng JY; Mu F; Liao MT; Yao F; Li L; Liu CY; Chen JB; Zuo JS; Xu KC
    World J Gastroenterol; 2013 Jun; 19(22):3473-80. PubMed ID: 23801841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the monoclonal antibody anti-HER2 trastuzumab in the treatment of metastatic breast cancer: a cost-effectiveness analysis.
    Poncet B; Bachelot T; Colin C; Ganne C; Jaisson-Hot I; Orfeuvre H; Peaud PY; Jacquin JP; Salles B; Tigaud JD; Mechin-Cretinon I; Marechal F; Fournel C; Trillet-Lenoir V
    Am J Clin Oncol; 2008 Aug; 31(4):363-8. PubMed ID: 18845995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible clinical cure of metastatic breast cancer: lessons from our 30-year experience with oligometastatic breast cancer patients and literature review.
    Kobayashi T; Ichiba T; Sakuyama T; Arakawa Y; Nagasaki E; Aiba K; Nogi H; Kawase K; Takeyama H; Toriumi Y; Uchida K; Kobayashi M; Kanehira C; Suzuki M; Ando N; Natori K; Kuraishi Y
    Breast Cancer; 2012 Jul; 19(3):218-37. PubMed ID: 22532161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cells combining with cytokine-induced killer cells synergize chemotherapy in patients with late-stage non-small cell lung cancer.
    Zhong R; Teng J; Han B; Zhong H
    Cancer Immunol Immunother; 2011 Oct; 60(10):1497-502. PubMed ID: 21681372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized trial of high-dose chemotherapy with autologous peripheral-blood stem-cell support compared with standard-dose chemotherapy in women with metastatic breast cancer: NCIC MA.16.
    Crump M; Gluck S; Tu D; Stewart D; Levine M; Kirkbride P; Dancey J; O'Reilly S; Shore T; Couban S; Girouard C; Marlin S; Shepherd L; Pritchard KI
    J Clin Oncol; 2008 Jan; 26(1):37-43. PubMed ID: 18025439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor.
    Babiera GV; Rao R; Feng L; Meric-Bernstam F; Kuerer HM; Singletary SE; Hunt KK; Ross MI; Gwyn KM; Feig BW; Ames FC; Hortobagyi GN
    Ann Surg Oncol; 2006 Jun; 13(6):776-82. PubMed ID: 16614878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longterm results and prognostic indicators after cryotherapy and hepatic arterial chemotherapy with or without resection for colorectal liver metastases in 224 patients: longterm survival can be achieved in patients with multiple bilateral liver metastases.
    Yan TD; Padang R; Morris DL
    J Am Coll Surg; 2006 Jan; 202(1):100-11. PubMed ID: 16377503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrence and survival outcomes after hepatic resection with or without cryotherapy for liver metastases from colorectal carcinoma.
    Niu R; Yan TD; Zhu JC; Black D; Chu F; Morris DL
    Ann Surg Oncol; 2007 Jul; 14(7):2078-87. PubMed ID: 17473951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to second-line chemotherapy in patients with metastatic breast carcinoma previously responsive to first-line treatment: prognostic factors.
    Brun B; Benchalal M; Lebas C; Piedbois P; Lin M; Lebourgeois JP
    Cancer; 1997 Jun; 79(11):2137-46. PubMed ID: 9179060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive factors for efficacy of capecitabine in heavily pretreated patients with metastatic breast cancer.
    Osako T; Ito Y; Ushijima M; Takahashi S; Tokudome N; Sugihara T; Iwase T; Matsuura M; Hatake K
    Cancer Chemother Pharmacol; 2009 Apr; 63(5):865-71. PubMed ID: 18670777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of celecoxib on capecitabine tolerability and activity in pretreated metastatic breast cancer: results of a phase II study with biomarker evaluation.
    Fabi A; Metro G; Papaldo P; Mottolese M; Melucci E; Carlini P; Sperduti I; Russillo M; Gelibter A; Ferretti G; Tomao S; Milella M; Cognetti F
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):717-25. PubMed ID: 18071704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryoablation of malignant liver tumors: results of a single center study.
    Jungraithmayr W; Burger D; Olschewski M; Eggstein S
    Hepatobiliary Pancreat Dis Int; 2005 Nov; 4(4):554-60. PubMed ID: 16286261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic cryotherapy and regional chemotherapy with or without resection for liver metastases from colorectal carcinoma: how many are too many?
    Yan DB; Clingan P; Morris DL
    Cancer; 2003 Jul; 98(2):320-30. PubMed ID: 12872352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.